Literature DB >> 30808805

Mechanism of glucocerebrosidase activation and dysfunction in Gaucher disease unraveled by molecular dynamics and deep learning.

Raquel Romero1, Arvind Ramanathan2, Tony Yuen3,4, Debsindhu Bhowmik2, Mehr Mathew4, Lubna Bashir Munshi4, Seher Javaid4, Madison Bloch4, Daria Lizneva3,4, Alina Rahimova3,4, Ayesha Khan4, Charit Taneja3,4, Se-Min Kim3,4, Li Sun3,4, Maria I New5, Shozeb Haider6, Mone Zaidi7,4.   

Abstract

The lysosomal enzyme glucocerebrosidase-1 (GCase) catalyzes the cleavage of a major glycolipid glucosylceramide into glucose and ceramide. The absence of fully functional GCase leads to the accumulation of its lipid substrates in lysosomes, causing Gaucher disease, an autosomal recessive disorder that displays profound genotype-phenotype nonconcordance. More than 250 disease-causing mutations in GBA1, the gene encoding GCase, have been discovered, although only one of these, N370S, causes 70% of disease. Here, we have used a knowledge-based docking protocol that considers experimental data of protein-protein binding to generate a complex between GCase and its known facilitator protein saposin C (SAPC). Multiscale molecular-dynamics simulations were used to study lipid self-assembly, membrane insertion, and the dynamics of the interactions between different components of the complex. Deep learning was applied to propose a model that explains the mechanism of GCase activation, which requires SAPC. Notably, we find that conformational changes in the loops at the entrance of the substrate-binding site are stabilized by direct interactions with SAPC and that the loss of such interactions induced by N370S and another common mutation, L444P, result in destabilization of the complex and reduced GCase activation. Our findings provide an atomistic-level explanation for GCase activation and the precise mechanism through which N370S and L444P cause Gaucher disease.

Entities:  

Keywords:  gene mutations; lysosomal storage disease; multiscale simulations; rare disease

Mesh:

Substances:

Year:  2019        PMID: 30808805      PMCID: PMC6421449          DOI: 10.1073/pnas.1818411116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

1.  Evaluation of protein docking predictions using Hex 3.1 in CAPRI rounds 1 and 2.

Authors:  David W Ritchie
Journal:  Proteins       Date:  2003-07-01

2.  The Amber biomolecular simulation programs.

Authors:  David A Case; Thomas E Cheatham; Tom Darden; Holger Gohlke; Ray Luo; Kenneth M Merz; Alexey Onufriev; Carlos Simmerling; Bing Wang; Robert J Woods
Journal:  J Comput Chem       Date:  2005-12       Impact factor: 3.376

3.  Functional organization of saposin C. Definition of the neurotrophic and acid beta-glucosidase activation regions.

Authors:  X Qi; W Qin; Y Sun; K Kondoh; G A Grabowski
Journal:  J Biol Chem       Date:  1996-03-22       Impact factor: 5.157

4.  Crystal structures of saposins A and C.

Authors:  Victoria E Ahn; Paul Leyko; Jean-René Alattia; Lu Chen; Gilbert G Privé
Journal:  Protein Sci       Date:  2006-07-05       Impact factor: 6.725

5.  Identification of the binding and activating sites of the sphingolipid activator protein, saposin C, with glucocerebrosidase.

Authors:  S Weiler; Y Kishimoto; J S O'Brien; J A Barranger; J M Tomich
Journal:  Protein Sci       Date:  1995-04       Impact factor: 6.725

6.  Human acid beta-glucosidase. Use of inhibitory and activating monoclonal antibodies to investigate the enzyme's catalytic mechanism and saposin A and C binding sites.

Authors:  D Fabbro; G A Grabowski
Journal:  J Biol Chem       Date:  1991-08-15       Impact factor: 5.157

7.  Gaucher disease due to saposin C deficiency, previously described as non-neuronopathic form--no positive effects after 2-years of miglustat therapy.

Authors:  Anna Tylki-Szymańska; Johanna E M Groener; Marek Leszek Kamiński; Agnieszka Ługowska; Elżbieta Jurkiewicz; Barbara Czartoryska
Journal:  Mol Genet Metab       Date:  2011-09-16       Impact factor: 4.797

Review 8.  Lysosomal degradation of membrane lipids.

Authors:  Thomas Kolter; Konrad Sandhoff
Journal:  FEBS Lett       Date:  2009-10-16       Impact factor: 4.124

9.  Crystal structures of human saposins C andD: implications for lipid recognition and membrane interactions.

Authors:  Maxim Rossmann; Robert Schultz-Heienbrok; Joachim Behlke; Natascha Remmel; Claudia Alings; Konrad Sandhoff; Wolfram Saenger; Timm Maier
Journal:  Structure       Date:  2008-05       Impact factor: 5.006

10.  Characterization of the ERAD process of the L444P mutant glucocerebrosidase variant.

Authors:  Inna Bendikov-Bar; Idit Ron; Mirella Filocamo; Mia Horowitz
Journal:  Blood Cells Mol Dis       Date:  2010-11-23       Impact factor: 3.039

View more
  13 in total

1.  Molecular models should not be published without the corresponding atomic coordinates.

Authors:  Stephen C Graham; Bhushan Nagar; Gilbert G Privé; Janet E Deane
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-04       Impact factor: 11.205

2.  Reply to Graham et al.: In silico atomistic coordinates and molecular dynamics simulation trajectories of the glucocerebrosidase-saposin C complex.

Authors:  Raquel Romero; Tony Yuen; Maria I New; Mone Zaidi; Shozeb Haider
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-04       Impact factor: 11.205

3.  The Role of Hydrophobic Nodes in the Dynamics of Class A β-Lactamases.

Authors:  Edgar Olehnovics; Junqi Yin; Adrià Pérez; Gianni De Fabritiis; Robert A Bonomo; Debsindhu Bhowmik; Shozeb Haider
Journal:  Front Microbiol       Date:  2021-09-21       Impact factor: 5.640

4.  Mapping Sphingolipid Metabolism Pathways during Phagosomal Maturation.

Authors:  Neelay Mehendale; Roop Mallik; Siddhesh S Kamat
Journal:  ACS Chem Biol       Date:  2021-10-14       Impact factor: 5.100

Review 5.  Protein Function Analysis through Machine Learning.

Authors:  Chris Avery; John Patterson; Tyler Grear; Theodore Frater; Donald J Jacobs
Journal:  Biomolecules       Date:  2022-09-06

6.  AI-Driven Multiscale Simulations Illuminate Mechanisms of SARS-CoV-2 Spike Dynamics.

Authors:  Lorenzo Casalino; Abigail Dommer; Zied Gaieb; Emilia P Barros; Terra Sztain; Surl-Hee Ahn; Anda Trifan; Alexander Brace; Anthony Bogetti; Heng Ma; Hyungro Lee; Matteo Turilli; Syma Khalid; Lillian Chong; Carlos Simmerling; David J Hardy; Julio D C Maia; James C Phillips; Thorsten Kurth; Abraham Stern; Lei Huang; John McCalpin; Mahidhar Tatineni; Tom Gibbs; John E Stone; Shantenu Jha; Arvind Ramanathan; Rommie E Amaro
Journal:  bioRxiv       Date:  2020-11-20

7.  Semi-rational design and molecular dynamics simulations study of the thermostability enhancement of cellobiose 2-epimerases.

Authors:  Qiuming Chen; Yaqin Xiao; Eugene I Shakhnovich; Wenli Zhang; Wanmeng Mu
Journal:  Int J Biol Macromol       Date:  2019-11-13       Impact factor: 6.953

Review 8.  Gaucher disease: Basic and translational science needs for more complete therapy and management.

Authors:  Gregory A Grabowski; Armand H M Antommaria; Edwin H Kolodny; Pramod K Mistry
Journal:  Mol Genet Metab       Date:  2020-12-29       Impact factor: 4.797

Review 9.  Artificial Intelligence (AI) in Rare Diseases: Is the Future Brighter?

Authors:  Sandra Brasil; Carlota Pascoal; Rita Francisco; Vanessa Dos Reis Ferreira; Paula A Videira; And Gonçalo Valadão
Journal:  Genes (Basel)       Date:  2019-11-27       Impact factor: 4.096

Review 10.  Rapid, accurate, precise and reproducible ligand-protein binding free energy prediction.

Authors:  Shunzhou Wan; Agastya P Bhati; Stefan J Zasada; Peter V Coveney
Journal:  Interface Focus       Date:  2020-10-16       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.